TY - JOUR
T1 - Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety
AU - De Corte, P.
AU - Verween, G.
AU - Verbeken, Gilbert
AU - Rose, T.
AU - Jennes, S.
AU - De Coninck, Arlette
AU - Roseeuw, Diane
AU - Vanderkelen, Alain
AU - Kets, E.
AU - Haddow, David
AU - Pirnay, Jean-Paul
PY - 2012/3
Y1 - 2012/3
N2 - Abstract: Since 1987, keratinocytes have been cultured at the Queen Astrid Military Hospital. These keratinocytes have been used routinely as auto and allografts on more than 1,000 patients, primarily to accelerate the healing of burns and chronic wounds. Initially the method of Rheinwald and Green was used to prepare cultured epithelial autografts, starting from skin samples from burn patients and using animal-derived feeder layers and media containing animal-derived products. More recently we systematically optimised our production system to accommodate scientific advances and legal changes. An important step was the removal of the mouse fibroblast feeder layer from the cell culture system. Thereafter we introduced neonatal foreskin keratinocytes (NFK) as source of cultured epithelial allografts, which significantly increased the consistency and the reliability of our cell production. NFK master and working cell banks were established, which were extensively screened and characterised. An ISO 9001 certified Quality Management System (QMS) governs all aspects of testing, validation and traceability. Finally, as far as possible, animal components were systematically removed from the cell culture environment. Today, quality controlled allograft production batches are routine and, due to efficient cryopreservation, stocks are created for off-the-shelf use. These optimisations have significantly increased the performance, usability, quality and safety of our allografts. This paper describes, in detail, our current cryopreserved allograft production process.
AB - Abstract: Since 1987, keratinocytes have been cultured at the Queen Astrid Military Hospital. These keratinocytes have been used routinely as auto and allografts on more than 1,000 patients, primarily to accelerate the healing of burns and chronic wounds. Initially the method of Rheinwald and Green was used to prepare cultured epithelial autografts, starting from skin samples from burn patients and using animal-derived feeder layers and media containing animal-derived products. More recently we systematically optimised our production system to accommodate scientific advances and legal changes. An important step was the removal of the mouse fibroblast feeder layer from the cell culture system. Thereafter we introduced neonatal foreskin keratinocytes (NFK) as source of cultured epithelial allografts, which significantly increased the consistency and the reliability of our cell production. NFK master and working cell banks were established, which were extensively screened and characterised. An ISO 9001 certified Quality Management System (QMS) governs all aspects of testing, validation and traceability. Finally, as far as possible, animal components were systematically removed from the cell culture environment. Today, quality controlled allograft production batches are routine and, due to efficient cryopreservation, stocks are created for off-the-shelf use. These optimisations have significantly increased the performance, usability, quality and safety of our allografts. This paper describes, in detail, our current cryopreserved allograft production process.
KW - HUMAN EPIDERMAL-KERATINOCYTES
KW - CHRONIC POSTOPERATIVE OTORRHEA
KW - XENOBIOTIC-FREE CULTURE
KW - GRAFT DONOR SITES
KW - LEG ULCERS
KW - AUTOLOGOUS KERATINOCYTES
KW - BURN WOUNDS
KW - ALLOGRAFTS
KW - EPITHELIUM
M3 - Article
VL - 1
SP - 175
EP - 189
JO - Cell and Tissue Banking
JF - Cell and Tissue Banking
SN - 1389-9333
IS - 13
ER -